Skip to Main Content

Paper Details

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.
J Immunother Cancer
38
2021
CTLA-4, PD-1, PD-L1, VEGF, advanced solid tumors, anti-programmed death 1, cancer, cytotoxic T lymphocyte-associated antigen-4, patient, programmed death ligand 1, vascular endothelial growth factor
Author NameAffiliation
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Howard ColmanHuntsman Cancer Institute, University of Utah
Howard ColmanHuntsman Cancer Institute, University of Utah
Simon KhagiUniversity of North Carolina at Chapel Hill School of Medicine
Minesh P MehtaMiami Cancer Institute
Amy B HeimbergerNorthwestern University
Vinay K PuduvalliThe University of Texas MD Anderson Cancer Center
Donald A BerryUniversity of Texas MD Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2